These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 22578805)
1. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program. Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805 [TBL] [Abstract][Full Text] [Related]
2. Newborn screening for Pompe disease in Japan. Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784 [TBL] [Abstract][Full Text] [Related]
3. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449 [TBL] [Abstract][Full Text] [Related]
4. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426 [TBL] [Abstract][Full Text] [Related]
5. Newborn screening for Pompe disease: an update, 2011. Burton BK Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry. Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766 [TBL] [Abstract][Full Text] [Related]
8. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots. Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480 [TBL] [Abstract][Full Text] [Related]
9. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment. Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening. Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296 [TBL] [Abstract][Full Text] [Related]
12. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients. Momosaki K; Kido J; Yoshida S; Sugawara K; Miyamoto T; Inoue T; Okumiya T; Matsumoto S; Endo F; Hirose S; Nakamura K J Hum Genet; 2019 Aug; 64(8):741-755. PubMed ID: 31076647 [TBL] [Abstract][Full Text] [Related]
13. The Initial Evaluation of Patients After Positive Newborn Screening: Recommended Algorithms Leading to a Confirmed Diagnosis of Pompe Disease. Burton BK; Kronn DF; Hwu WL; Kishnani PS; Pediatrics; 2017 Jul; 140(Suppl 1):S14-S23. PubMed ID: 29162674 [TBL] [Abstract][Full Text] [Related]
14. Mutations in GAA Gene in Tunisian Families with Infantile Onset Pompe Disease: Novel Mutation and Structural Modeling Investigations. Alila-Fersi O; Aloulou H; Werteni I; Mahfoudh N; Chabchoub I; Kammoun H; Keskes L; Hachicha M; Belguith N; Fakhfakh F J Mol Neurosci; 2020 Jul; 70(7):1100-1109. PubMed ID: 32125626 [TBL] [Abstract][Full Text] [Related]
15. Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Chien YH; Lee NC; Thurberg BL; Chiang SC; Zhang XK; Keutzer J; Huang AC; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL Pediatrics; 2009 Dec; 124(6):e1116-25. PubMed ID: 19948615 [TBL] [Abstract][Full Text] [Related]
16. Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in Taiwan. Liao HC; Chiang CC; Niu DM; Wang CH; Kao SM; Tsai FJ; Huang YH; Liu HC; Huang CK; Gao HJ; Yang CF; Chan MJ; Lin WD; Chen YJ Clin Chim Acta; 2014 Apr; 431():80-6. PubMed ID: 24513544 [TBL] [Abstract][Full Text] [Related]
17. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease. Wang Z; Okamoto P; Keutzer J Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919 [TBL] [Abstract][Full Text] [Related]
18. Pompe disease: early diagnosis and early treatment make a difference. Chien YH; Hwu WL; Lee NC Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029 [TBL] [Abstract][Full Text] [Related]
19. Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease. Liao HC; Chan MJ; Yang CF; Chiang CC; Niu DM; Huang CK; Gelb MH Clin Chem; 2017 Jul; 63(7):1271-1277. PubMed ID: 28450385 [TBL] [Abstract][Full Text] [Related]
20. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease. Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]